We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+8.79%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$17.7B
AUM Growth
+$2.98B
(+20%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
10.19%
Top 10 Holdings %
Top 10 Hldgs %
35.18%
Holding
1,173
New
33
Increased
727
Reduced
328
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$505M |
| 2 |
Intel
INTC
|
+$122M |
| 3 |
Apple
AAPL
|
+$122M |
| 4 |
Microsoft
MSFT
|
+$98.1M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$90.1M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$37.3M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$32.8M |
| 4 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$15.9M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$15.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.79% |
| 2 | Financials | 10.21% |
| 3 | Healthcare | 7.68% |
| 4 | Consumer Discretionary | 4.29% |
| 5 | Energy | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
First Horizon
FHN
$12.1B
| $7.63M | 0.04% |
677,203
+278,517
| +70% | +$3.73M |
|
302
Pinnacle Financial Partners Inc
PNFP
$15.8B
| $7.63M | 0.04% |
134,722
+54,317
| +68% | +$2.86M |
|
303
SM Energy
SM
$7.58B
| $7.63M | 0.04% |
241,218
-61,480
| -20% | -$1.74M |
|
304
AT&T
T
$159B
| $7.62M | 0.04% |
478,046
+46,944
| +11% | +$800K |
|
|
ETNB
305
DELISTED
89bio
ETNB
| $7.62M | 0.04% |
401,851
+82,353
| +26% | +$1.45M |
|
|
PACW
306
DELISTED
PacWest Bancorp
PACW
| $7.58M | 0.04% |
929,661
+600,374
| +182% | +$4.84M |
|
307
Antero Resources
AR
$10.9B
| $7.57M | 0.04% |
328,719
-43,703
| -12% | -$971K |
|
308
Boston Scientific
BSX
$68.4B
| $7.53M | 0.04% |
139,156
+10,990
| +9% | +$574K |
|
309
TG Therapeutics
TGTX
$8.19B
| $7.51M | 0.04% |
302,528
-180,507
| -37% | -$4.66M |
|
310
L3Harris
LHX
$50.7B
| $7.47M | 0.04% |
38,166
-676
| -2% | -$129K |
|
311
Ultragenyx Pharmaceutical
RARE
$2.56B
| $7.46M | 0.04% |
161,675
-13,900
| -8% | -$645K |
|
|
MORF
312
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $7.46M | 0.04% |
130,079
+71,298
| +121% | +$3.72M |
|
313
Sarepta Therapeutics
SRPT
$1.64B
| $7.44M | 0.04% |
65,004
+16,358
| +34% | +$2.11M |
|
314
Western Alliance Bancorporation
WAL
$8.87B
| $7.41M | 0.04% |
203,282
+42,166
| +26% | +$1.46M |
|
315
Iovance Biotherapeutics
IOVA
$2.09B
| $7.41M | 0.04% |
1,052,921
-42,518
| -4% | -$304K |
|
|
PR
316
Permian Resources
PR
$17.6B
| $7.4M | 0.04% |
675,506
-135,914
| -17% | -$1.39M |
|
317
SouthState Bank Corp
SSB
$10.2B
| $7.39M | 0.04% |
112,369
+61,666
| +122% | +$4.12M |
|
|
AKRO
318
DELISTED
Akero Therapeutics
AKRO
| $7.39M | 0.04% |
158,272
-6,231
| -4% | -$286K |
|
319
GlobalFoundries
GFS
$27.4B
| $7.38M | 0.04% |
114,307
+35,911
| +46% | +$2.17M |
|
320
Prosperity Bancshares
PB
$8.97B
| $7.36M | 0.04% |
130,240
+61,728
| +90% | +$3.69M |
|
321
Valley National Bancorp
VLY
$7.92B
| $7.34M | 0.04% |
947,435
+548,147
| +137% | +$4.36M |
|
|
CPE
322
DELISTED
Callon Petroleum Company
CPE
| $7.34M | 0.04% |
209,355
-14,107
| -6% | -$472K |
|
323
Denali Therapeutics
DNLI
$3.86B
| $7.33M | 0.04% |
248,526
-8,447
| -3% | -$238K |
|
324
Cytokinetics
CYTK
$10.9B
| $7.32M | 0.04% |
224,424
+33,270
| +17% | +$1.23M |
|
325
Wintrust Financial
WTFC
$10.8B
| $7.27M | 0.04% |
100,108
+41,500
| +71% | +$2.83M |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Rafferty Asset Management held 1,173 positions worth $17.7B, up 20% from $14.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Rafferty Asset Management deployed $1.81B of net new capital in Q2 2023, opening 33 new positions and adding to 727 existing holdings. Its largest new stake was Biomea Fusion: 136,903 shares worth $3.01M.
By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 42% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $90.1M trimmed.
- Rafferty Asset Management's largest Q2 2023 buy was Biomea Fusion: 136,903 shares worth $3.01M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q2 2023, an estimated $505M increase.
- Rafferty Asset Management's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $90.1M.
- Rafferty Asset Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $6.38M.
- Rafferty Asset Management's ten largest holdings make up 35% of its $17.7B portfolio in Q2 2023.
- Rafferty Asset Management opened 33 new positions and closed 84 in Q2 2023.
- Rafferty Asset Management's portfolio value rose 20% quarter-over-quarter to $17.7B.
Based on Rafferty Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.